Bullboard Post History

by DJDawg

Order by:

V.TLT	RE:RE:Various thoughts Interesting observations. I don't know much about shorting but the whole... December 1, 2023
V.TLT	RE:RE:Various thoughts I'm guessing. Take with a grain of salt. November 30, 2023
V.TLT	Various thoughts The PP success or lack of success - this was a shot in the foot moment of TLT... November 30, 2023
V.TLT	RE:RE:RE:It’s going to take a longggggg time I bet Validating through a central lab is a complicated way of saying the following... November 29, 2023
V.TLT	RE:It’s going to take a longggggg time I bet I'm confused as to what you are describing. There is no tracking and... November 29, 2023
V.TLT	RE:RE:RE:RE:RE:RE:RE:RE:RE:Exploring NMIBC Options in the face of BCG Shortages nope. 6 + 24 (one a month) = 30 total in 2 yrs if they are doing the whole... November 27, 2023
V.TLT	RE:RE:RE:RE:RE:RE:RE:Exploring NMIBC Options in the face of BCG Shortages Regrets on being late to the gem/doce discussion. The protocol for the main... November 27, 2023
V.TLT	RE:RE:RE:RE:RE:Exploring NMIBC Options in the face of BCG Shortages Dr. Kamat is on the MAB for TLT so it would be exceptionally tricky for him... November 24, 2023
V.TLT	RE:RE:RE:RE:QUILT-3.032 Trial - BCG & N-803 for BCG-Unresponsive NMIBC They are a bigger company on the NASDAQ and have a lot of pipelines on the go... November 23, 2023
V.TLT	RE:QUILT-3.032 Trial - BCG & N-803 for BCG-Unresponsive NMIBC Great post Eog. What an intense protocol. I wish the drugs would be judged... November 21, 2023
V.TLT	RE:Longterm Treatment Followup Awesome find Eog. I totally agree that the FDA has been burned lately with a... November 20, 2023
V.TLT	RE:RE:RE:RE:RE:RE:List goes on and on All good gebremeskel. :) Agree that details should be consistently... November 19, 2023
V.TLT	RE:RE:RE:RE:List goes on and on You make a valid point Gebremeskel. I will rephrase what I meant. Most... November 19, 2023
V.TLT	RE:RE:List goes on and on This is the list I was referencing in my post. Didn't attach. 1. OSC... November 18, 2023
V.TLT	RE:List goes on and on People are calling each other pumpers and bashers....can't we just strike... November 18, 2023
V.TLT	RE:RE:RE:RE:RE:-43% down YTD my recollection was that the posters in question said some very very toxic... November 18, 2023
V.TLT	RE:RE:RE:RE:RE:RE:RE:Information void Sorry. Not sure for sure but I think all they are pulling in this round is 1... November 18, 2023
V.TLT	RE:RE:RE:RE:RE:RE:RE:Information void I'll hang to to minor threads of hope. I love the science but the... November 17, 2023
V.TLT	RE:RE:RE:RE:RE:Information void I think that the 1.5 million is not a coincidence. The other company that I... November 17, 2023
V.TLT	Information void As usual we sit in a void with no updates on the LIFE offering. I followed... November 17, 2023

Become a member today, It's free!

Bullboard Post History

by DJDawg

RE:RE:Various thoughts

RE:RE:Various thoughts

Various thoughts

RE:RE:RE:It’s going to take a longggggg time I bet

RE:It’s going to take a longggggg time I bet

RE:RE:RE:RE:RE:RE:RE:RE:RE:Exploring NMIBC Options in the face of BCG Shortages

RE:RE:RE:RE:RE:RE:RE:Exploring NMIBC Options in the face of BCG Shortages

RE:RE:RE:RE:RE:Exploring NMIBC Options in the face of BCG Shortages

RE:RE:RE:RE:QUILT-3.032 Trial - BCG & N-803 for BCG-Unresponsive NMIBC

RE:QUILT-3.032 Trial - BCG & N-803 for BCG-Unresponsive NMIBC

RE:Longterm Treatment Followup

RE:RE:RE:RE:RE:RE:List goes on and on

RE:RE:RE:RE:List goes on and on

RE:RE:List goes on and on

RE:List goes on and on

RE:RE:RE:RE:RE:-43% down YTD

RE:RE:RE:RE:RE:RE:RE:Information void

RE:RE:RE:RE:RE:RE:RE:Information void

RE:RE:RE:RE:RE:Information void

Information void

Featured Company

K9 Gold Corp V.KNC

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by DJDawg

Featured Company